GSTM1 and chronic kidney disease: While two studies showed no effect of vitamin D on Hb levels [19, 20], two other studies showed significant decreases in the required dose of erythropoietin (EPO) and erythropoiesis stimulating agents (ESA) in the vitamin D group in patients with chronic kidney disease, respectively [18–21].